Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 831-109-9 | CAS number: 5837-73-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2021-06-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 2019-06-18, corrected 2020-06-26
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- methyl 2-hydroxybut-3-enoate
- EC Number:
- 831-109-9
- Cas Number:
- 5837-73-0
- Molecular formula:
- C5H8O3
- IUPAC Name:
- methyl 2-hydroxybut-3-enoate
Constituent 1
In chemico test system
- Details of test system:
- cysteine peptide, (Ac-RFAACAA-COOH)
- lysine peptide (Ac-RFAAKAACOOH)
- Details on the study design:
- PREPARATION OF TEST SOLUTIONS
- Preparation of the peptide/derivative stock solutions:
Cysteine peptide stock solution, 0.667 mM, 0.501 mg/mL: 0.01121 g of the peptide was pre-weighted and 20.158 mL of pH 7.5 phosphate buffer was added right before beginning the assay.
Lysine peptide stock solution, 0.667 mM, 0.518 mg/mL: 0.01033 g of the peptide was pre-weightedand 18.725 mL of pH 10.2 acetate buffer was added right before beginning of the assay.
- Preparation of the test chemical solutions: 100 mM solutions of the test chemical in the appropriate solvent were prepared just before use. The needed amount of test chemical was calculated (0.0234 g) based on the molecular weight and purity of the substance. 0.0234 g test chemical was weighted for the stock solutions used for the cysteine peptide depletion determination respectively and 0.0233 g test chemical was weighted for the stock solution used for lysine peptide depletion determination.
- Preparation of the positive controls, reference controls and co-elution controls
Positive control: 100 mM solutions of the positive control chemical in acetonitrile were prepared just before use. The needed amount of test chemical was calculated (0.0664 g ± 10%) based on the molecular weight and purity of the substance. 0.0663 g cinnamaldehyde was weighted for the positive stock solution used for the cysteine peptide depletion determination and 0.0661 g cinnamaldehyde was weighted for the stock solution used for lysine peptide depletion determination in the runs.
Reference control A: Peptide stock solutions are combined with acetonitrile. System suitability is checked by the use of the three replicates of reference control A.
Reference control B: Peptide stock solutions are combined with acetonitrile. Stability of the peptides are checked by the use of the three replicates of reference control B, measured before and after of the reaction samples.
Reference control C: Peptide stock solutions are combined with the respective solvent of the test item (and acetonitrile in case of cysteine peptide). Three replicates of reference control C are used as a solvent control to which the peptide concentration/depletion of the reaction samples is compared. Since acetonitrile is not the chosen solvent for the test item, a reference control C with acetonitrile is prepared additionally as the solvent control for the positive control.
Co-elution controls: Test item stock solution (and acetonitrile in case of cysteine peptide) is combined with the respective buffer solutions in each run. Co-elution controls are used to check for test item and peptide co-elution.
INCUBATION
- Incubation conditions: The vials were capped, vortexed to mix and placed to the HPLC autosampler for 24 ± 2 h incubation at 22.5°C - 30°C in the dark. HPLC analysis of the batch of reaction samples started 24 ± 2 h hours after the test chemical was added to the peptide solution
- Precipitation noted: No precipitation was noted.
PREPARATION OF THE HPLC
- Standard calibration curve for both Cys and Lys: Six calibration standard points were prepared by serial dilution of the peptide stock solutions with the following nominal molarities: STD 1 = 0.534 mM, STD 2 = 0.267 mM, STD 3 = 0.1335 mM, STD 4 = 0.0667 mM, STD 5 = 0.0334 mM and STD 6 = 0.0167 mM. As dilution buffer a 20% acetonitrile:buffer solution (phosphate or ammonium acetate) was used. For the zero standard point (STD 7 = 0 mM) dilution buffer was used.
- Verification of the suitability of the HPLC for test chemical and control substances: Prior to routine use of the method, the laboratory demonstrated technical proficiency in a separate study (Study number.: 392-442-2996) by correctly obtaining the expected DPRA prediction for 10 proficiency substances as recommended in the OECD TG 442C guideline.
DATA EVALUATION
- Cys and Lys peptide detection wavelength: 200 nm - Vehicle / solvent:
- water
- Positive control:
- cinnamic aldehyde
Results and discussion
- Positive control results:
- The acceptance criteria were met for the positive control with a cysteine peptide depletion value of 67.22 % ± 0.51 % and with lysine peptide depletion value of 52.07 % ± 1.33 %.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Group:
- test chemical
- Run / experiment:
- mean
- Parameter:
- mean lysine depletion
- Value:
- 1.88 %
- At concentration:
- 100 mM
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no relevant increase
- Key result
- Group:
- test chemical
- Run / experiment:
- mean
- Parameter:
- mean cystein depletion
- Value:
- 1.24 %
- At concentration:
- 100 mM
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no relevant increase
- Outcome of the prediction model:
- no or minimal reactivity [in chemico]
- Other effects / acceptance of results:
- DEMONSTRATION OF TECHNICAL PROFICIENCY:
Prior to routine use of the method, the laboratory demonstrated technical proficiency in a separate study (Study number.: 392-442-2996) by correctly obtaining the expected DPRA prediction for 10 proficiency substances as recommended in the OECD TG 442C guideline.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for reference controls A to C: Yes
- Acceptance criteria met for co-elution controls (Lysine and Cysteine): Yes
- Acceptance criteria met for variability between replicate measurements: Yes
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- The DPRA prediction must be considered in the framework of an IATA for a final prediction.
- Conclusions:
- In the in chemico Direct Peptide Reactivity Assay (DPRA) according to OECD guideline 442C, the test item showed no or minimal reactivity towards the synthetic peptides; thus it is not a potential skin sensitizer under the experimental conditions.
- Executive summary:
In the course of this study the skin sensitization potential of the test item was studied using the Direct Peptide Reactivity Assay (DPRA) in accordance with OECD 442C and GLP. For the test item and the positive control substance, in order to derive a prediction two independent tests were evaluated, one with cysteine and one with lysine peptides. The results of two valid runs is used for the classification of the test item. Peptide depletion by the positive control cinnamaldehyde was 67.22 % ± 0.51 % for cysteine peptides and 52.07 % ± 1.33 % for lysine peptides, fulfilling all acceptance criteria for the positive control.
The mean back-calculated peptide concentrations of the reference control A replicates were within the expected molarity concentration range for cysteine (0.49 mM) and lysine peptides (0.50 mM) and the CV % for the nine reference controls B and C in acetonitrile were 2.9 % and 0.2 % percentages for cysteine and lysine peptides, respectively. Moreover, the mean back-calculated peptide concentrations of the three reference controls C in the ultrapure water replicates were within the expected molarity concentration range for cysteine (0.47 mM) and lysine peptides (0.50 mM). For each peptide, all validity criteria were met, confirming the validity of the assay. The percent cysteine peptide depletion value of the test item was 1.24 % ± 2.72 % while the percent lysine peptide depletion was 1.88 % ± 0.46 %. The mean depletion value of the peptides was used to categorize the test chemical in one of the four classes of reactivity. No co-elution was observed with either cysteine or lysine peptides; therefore, the cysteine 1:10 / lysine 1:50 prediction model was used for the discrimination between sensitizers and non-sensitizers. The mean peptide depletion of the test item was 1.56 %, which is well below the threshold of 6.38 % for the applicable prediction model. The test item fells therefore into the no or minimal reactivity class and is evaluated not to be a skin sensitizer in this DPRA test.
Based on these results and the cysteine 1:10 / lysine 1:50 prediction model, the test item showed no or minimal reactivity towards the synthetic peptides; thus it is not a potential skin sensitizer under the experimental conditions of the in chemico Direct Peptide Reactivity Assay (DPRA) method according to OECD 442C.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.